Showing results (1451-1460 of 1,486) with videos related to

Sort By:
Pageof 149
The Lancet. Haematology|June 29, 2023
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trialMargaret V Ragni, Scott D Rothenberger, Robert Feldman, et al.
The Journal of Hospital Infection|June 12, 2023
Evaluating the cost implications of integrating SARS-CoV-2 genome sequencing for infection prevention and control investigation of nosocomial transmission within hospitalsM Panca, J Blackstone, O Stirrup, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2024
Viruses traverse the human proteome through peptide interfaces that can be biomimetically leveraged for drug discoveryLaurène Meyniel-Schicklin, Jérôme Amaudrut, Pierre Mallinjoud, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Structure-Guided Discovery of Selective Polo-Like Kinase 3 InhibitorsJeremy L Yap, Gabrielle Lovett, Jeremy W Mason, et al.
Pain|September 20, 2016
Cross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre studyRachel Wodarski, Ada Delaney, Camilla Ultenius, et al.
Interactive Journal of Medical Research|June 29, 2022
Synthesis of the Evidence on What Works for Whom in Telemental Health: Rapid Realist ReviewMerle Schlief, Katherine R K Saunders, Rebecca Appleton, et al.
Pain|November 8, 2016
Cross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre studyRachel Wodarski, Ada Delaney, Camilla Ultenius, et al.
The Lancet. Psychiatry|June 15, 2023
Mental health in Europe during the COVID-19 pandemic: a systematic reviewNafiso Ahmed, Phoebe Barnett, Anna Greenburgh, et al.
British Journal of Cancer|April 3, 2023
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)D Gareth Evans, Lorna McWilliams, Susan Astley, et al.
Journal of Medicinal Chemistry|August 30, 2011
Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary diseasePaul A Glossop, Christine A L Watson, David A Price, et al.
Pageof 149